✦ LIBER ✦

Does the Effect of Beta-Blockers on Outcomes in Patients with Advanced Chronic Systolic Heart Failure Vary by Baseline Systolic Blood Pressure? Insights from the BEST Trial

✍ Scribed by Michel White; Ravi V. Desai; Marjan Mujib; Mustafa I. Ahmed; Immaculada Aban; Gregg Fonarow; Prakash Deedwania; Wilbert S. Aronow; Finn Waagstein; Ali Ahmed

Book ID: 116340213
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 423 KB
Volume: 16
Category: Article
ISSN: 1532-8414
DOI: 10.1016/j.cardfail.2010.06.222

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of Baseline Systolic Blood Pressu

Impact of Baseline Systolic Blood Pressure on Long-Term Outcomes in Patients With Advanced Chronic Systolic Heart Failure (Insights from the BEST Trial)

✍ Ravi V. Desai; Maciej Banach; Mustafa I. Ahmed; Marjan Mujib; Inmaculada Aban; T 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 861 KB

SHOULD WE ANTICOAGULATE PATIENTS WITH AD

SHOULD WE ANTICOAGULATE PATIENTS WITH ADVANCED SYSTOLIC HEART FAILURE WITHOUT ATRIAL FIBRILLATION? INSIGHTS FROM THE BETA-BLOCKER EVALUATION OF SURVIVAL TRIAL (BEST)

✍ Marjan U. Mujib; Mustafa I. Ahmed; Wilbert S. Aronow; Prakash Deedwania; Ali Ahm 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 82 KB

THE EFFECT OF BETA-BLOCKERS ON MORTALITY

THE EFFECT OF BETA-BLOCKERS ON MORTALITY IN SYSTOLIC HEART FAILURE VARIES BY BASELINE RIGHT VENTRICULAR EJECTION FRACTION: A POST HOC ANALYSIS OF THE BEST TRIAL

✍ Ali Ahmed; Gilbert Perry; Gerasimos Filippatos; Marjan Mujib; Margaret Feller; Y 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 265 KB

Analysis of Randomized Controlled Trials

Analysis of Randomized Controlled Trials on the Effect of Magnitude of Heart Rate Reduction on Clinical Outcomes in Patients With Systolic Chronic Heart Failure Receiving Beta-Blockers

✍ Genevieve Flannery; Rosie Gehrig-Mills; Baki Billah; Henry Krum 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Effects on Outcomes of Heart Rate Reduct

Effects on Outcomes of Heart Rate Reduction by Ivabradine in Patients With Congestive Heart Failure: Is There an Influence of Beta-Blocker Dose?: Findings From the SHIFT (Systolic Heart failure treatment with the If inhibitor ivabradine Trial) Study

✍ Karl Swedberg; Michel Komajda; Michael Böhm; Jeffrey Borer; Michele Robertson; L 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 509 KB